News
Latest news
Morning Read: Non-profit designing free Wi-Fi architecture for hospitals
Organovo is hoping their 3-D printing process can create muscle cells that will improve the drug testing process. The West Wireless Health Institute is hoping an open source model will help wireless technology become as integral to hospitals as all other basic utilities. The goal for the institute’s new West Wireless Health Council is to create a [...]
Full storyIn this windowIn a new window
Managing retinal vein occlusion
Summary pointsRetinal vein occlusion is the second most common retinal vascular disease after diabetic retinopathyOcclusion can occur in the central retinal vein or, more commonly, in a branch...
Full storyIn this windowIn a new window
Let Me Die on the Prairie by Frances Jane Crosby Van Alstyne
Let me die on the prairie! and o’er my rude grave, In the soft breeze of summer the tall grass shall wave; I would breathe my last sigh as the bright hues of even Are melting away in the blue arch of Heaven.
Let me die on the prairie! unwept and unknown, I would pass from this fair Earth forgotten, alone;— Yet no! – there are hearts I have learned to revere, And methinks there is bliss in affection’s warm tear.
Oh, speak not to me of the green cypress shade; I would sleep where the bones of the Indian are laid, And the deer will bound o’er me with step light and free, And the carol of birds will my requiem be.
Let me die on the prairie! I have wished for it long; There floats in wild numbers the bold hunter’s song; ’Tis the spot of all others the dearest to me, And how sweet in its bosom my slumber will be!
Source: She Wields a Pen: American Women Poets of the Nineteenth Century (University of Iowa Press, 1997)
Full storyIn this windowIn a new window
Publication: Volume 16, number 4 (Stevenson). Study found that no conclusive results can be provided on the cost-effectiveness of four non-invasive tests for liver fibrosis [the Enhanced Liver Fibrosis Test, FibroTest and FibroMAX and transient elastography (FibroScan)] in patients suspected of having alcohol-related liver disease.
Chief Investigator: School of Health and Related Research (ScHARR-TAG), University of Sheffield
Research Type: HTA Technology Assessment Report
ICD Chapters: Methodology
Key Areas: NOT APPLICABLE
ICD Diseases: NOT APPLICABLE
Research Type: HTA Technology Assessment Report
Publication date: 20/02/2012
HTA project ref: 09/62/01
Full storyIn this windowIn a new window
Top headlines from HIMSS2012 (Tuesday edition)
Look for federal regulators to go easier on health systems and others, according to the HIMSS CEO. H. Stephen Lieber told InformationWeek that Stage 2 Meaningful Use requirements will be milder based on the experience of ICD-10 and Stage 1 Meaningful Use, among other things. Proposal rules for Stage 2 of Meaningful Use incentives for the adoption of electronic medical records are due out any day now. "We stand by the position we have established that the [ICD-10] deadline in isolation was reasonable," Lieber told InformationWeek. "Unfortunately, it's not in isolation," Lieber added. "It's also when [ANSI X12] 5010 conversion had to occur. It's in the middle of Stage 1 and Stage 2[of Meaningful Use]."
Full storyIn this windowIn a new window
Incidence of diabetic retinopathy in people with type 2 diabetes mellitus attending the Diabetic Retinopathy Screening Service for Wales: retrospective analysis
Objectives To determine the incidence of any and referable diabetic retinopathy in people with type 2 diabetes mellitus attending an annual screening service for retinopathy and whose first screening...
Full storyIn this windowIn a new window
Publication: Volume 16, number 3 (Hockenhull). Report finds that whilst some interventions targeted at mental health populations to reduce violence are well supported by the evidence a scattergun approach in the research literature provides little firm evidence for the majority of interventions. Evidence shows small-to-moderate effects for cognitive behavioural therapy for psychological interventions, and larger effects for atypical antipsychotic drugs.
Chief Investigator: Liverpool Reviews and Implementation Group (LRIG), University of Liverpool
Research Type: HTA Technology Assessment Report
ICD Chapters: External causes of injury/death
Key Areas: Public Safety
Interventions: General medical practice
ICD Diseases: Other health care
Research Type: HTA Technology Assessment Report
Publication date: 20/02/2012
HTA project ref: 08/101/01
Full storyIn this windowIn a new window
How the NHS measures up to other health systems
The government’s plans for reorganising the English National Health Service have sparked heated discussions about the performance of the UK health system in comparison with that of other countries....
Full storyIn this windowIn a new window
Publication: Volume 16, number 5 (Ara). Although orlistat, sibutramine and rimonabant are all effective at reducing weight and body mass index and, compared with placebo, are all cost-effective, both sibutramine and rimonabant have been withdrawn because of safety concerns relating to potential treatment-induced fatal adverse events.
Chief Investigator: Ms Roberta Ara, Operational Research Analyst, ScHARR, University of Sheffield
Research Type: Secondary Research (e.g. systematic review)
ICD Chapters: Endocrine, nutritional and metabolic diseases
Key Areas:
ICD Diseases: Obesity
Research Type: Secondary Research (e.g. systematic review)
Publication date: 20/02/2012
HTA project ref: 07/85/02
Full storyIn this windowIn a new window
Peter John Fenton
After qualifying Peter John Fenton (PF, as he was known to his colleagues) was appointed house surgeon to the eye department, and this early exposure convinced him that ophthalmology was to be his...
Full storyIn this windowIn a new window
Publication: Volume 16, number 6 (Reeves). The verteporfin photodynamic therapy cohort study found that treatment and follow-up were much less frequent in routine clinical practice than in research trials and the cost-effectiveness was similar to the highest previous estimate.
Chief Investigator: Professor Usha Chakravarthy, Professor of Ophthalmology and Vision Sciences, Centre for Vision Sciences, The Queen's University of Belfast Trust
Research Type: Primary Research (e.g. trial)
ICD Chapters: Eye diseases
Key Areas: Older people, Public Health
ICD Diseases: Age related macular degeneration
Research Type: Primary Research (e.g. trial)
Publication date: 21/02/2012
HTA project ref: 03/36/01
Full storyIn this windowIn a new window
Frederick Valentine Flynn
Frederick Valentine Flynn (“Freddie”) made major contributions to our understanding of proteinuria, taught clinical biochemistry to generations of medical students and medical and non-medical...
Full storyIn this windowIn a new window
ClinSearch tribune
Middle East: New Frontier for Medical Device Clinical Evidence
The Middle Eastern market for medical devices is displaying extraordinary growth and significant progress. Middle Eastern region, particularly oil wealthy countries, offers many incentives to conduct outsourced clinical trials…
Compliance — An opinion paper
Recently, healthcare systems have been attempting to “clean-up their act” and much attention is being brought to corruption and bribery. Medical Device and Pharmaceutical organizations are being targeted by anti-corruption and anti-bribery officials. Clinical evaluation still is not commonly used however it is undoubtedly the best way to demonstrate the benefits brought by your innovation. Clinical evaluation should be your first marketing decision. There is no alternative to enter the market durably…
Why you should perform a clinical investigation
Progress report LNE-America See here (online version/pdf version) our view on How Manufacturers Benefit from a Robust Clinical Assessment. Progress report of May 2011, published on the website of LNE America
Let clinical evidence
support innovation
Follow us:
Applications
|
|
|
|
|
|
|
|
|
|
|